Simplex Trading’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,083
Closed -$21K 7284
2017
Q3
$21K Buy
1,083
+489
+82% +$68.1K ﹤0.01% 3136
2017
Q2
$89K Buy
594
+188
+46% +$15.3K ﹤0.01% 1860
2017
Q1
$111K Buy
406
+214
+111% +$13.2K ﹤0.01% 1655
2016
Q4
$150K Sell
192
-304
-61% -$14.9K 0.01% 1242
2016
Q3
$157K Buy
496
+336
+210% +$18.7K 0.01% 1202
2016
Q2
$91K Buy
160
+80
+100% +$3.93K 0.01% 1550
2016
Q1
$54K Buy
80
+41
+105% +$1.99K ﹤0.01% 1898
2015
Q4
$26K Sell
39
-17
-30% -$1.2K ﹤0.01% 2492
2015
Q3
$54K Sell
56
-195
-78% -$12.3K ﹤0.01% 1944
2015
Q2
$114K Buy
251
+16
+7% +$913 0.01% 1136
2015
Q1
$135K Buy
235
+136
+137% +$9.12K 0.02% 919
2014
Q4
$10K Buy
+99
New +$4.17K ﹤0.01% 2621

Simplex Trading's KITE Position: Q4 2017 in Review

Simplex Trading sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 28,828 shares — an estimated $5.18M sold.

Simplex Trading first reported a position in KITE in Q4 2014 and held it in 5 quarters. The position peaked at $5.18M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Simplex Trading reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Simplex Trading sold 28,828 Kite Pharma, Inc. shares in Q4 2017, an estimated $5.18M.
  • Simplex Trading first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 5 quarters.
  • Simplex Trading's Kite Pharma, Inc. position peaked at $5.18M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Simplex Trading's 13F filing for Q4 2017, filed 10 Jan 2018.